...
首页> 外文期刊>Journal of cosmetic dermatology. >COVID vaccine recommendations in dermatologic patients on immunosuppressive agents: Lessons learned from pandemic
【24h】

COVID vaccine recommendations in dermatologic patients on immunosuppressive agents: Lessons learned from pandemic

机译:COVID vaccine recommendations in dermatologic patients on immunosuppressive agents: Lessons learned from pandemic

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background Since SARS‐CoV2 vaccines were approved without enough long‐term monitoring due to emergent situations, some issues have been raised about timing and protocol of receiving them by patients treated by different immunosuppressive agents. Aim and Method Here, we present different aspects of SARS‐CoV‐2 vaccination in such patients in the field of dermatology. Result In brief, SARS‐CoV‐2 vaccination is recommended in all dermatologic patients, regardless of their disorders and therapeutic regimens. Nevertheless, special considerations should be given to the immunosuppressive therapy and its association with vaccination timing due to the decreased immunogenicity of vaccines in this setting. Conclusion Novel biologic immunotherapies are advantageous over conventional systemic therapies not only in their safety and selective functions but also in this aspect that many of them do not affect vaccines immunogenicity.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号